Cochlear Investor Relations Material
Latest events
H2 2025
Cochlear
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cochlear Limited
Access all reports
Cochlear Limited is an Australia-based medical device company specializing in implantable hearing solutions. The company designs, manufactures, and distributes cochlear implants, bone conduction systems, and acoustic implants, providing solutions for individuals with moderate to profound hearing loss. Cochlear also offers a range of services and accessories to support patients and healthcare professionals throughout the hearing restoration process.
Key slides for Cochlear Limited
H2 2025
Cochlear Limited
H2 2025
Cochlear Limited
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
COH
Country
🇦🇺 Australia